What 2010 Planning Will Mean for Pharma and Biotech in 2011 RESEARCH TRIANGLE PARK, NC--(Marketwire - December 9, 2010) - As many companies put the finishing touches on their 2011 Action Plans, the pharmaceutical and biotechnology sectors are looking to...

Measuring Drug Safety ROI Is Difficult, but Feasible RESEARCH TRIANGLE PARK, NC--(Marketwire - June 17, 2010) -  Communicating return on investment (ROI) is a low priority for many drug safety and pharmacovigilance teams, says life sciences...

Drug Safety Outsourcing Requires Careful Scrutiny of Pros and Cons RESEARCH TRIANGLE PARK, NC--(Marketwire - May 25, 2010) -  A new research study shows that the decision to outsource pharmacovigilance activities is connected closely to company size, cultural...

Drug Safety Budgets Must Be Defended, ROI Measured RESEARCH TRIANGLE PARK, NC--(Marketwire - May 19, 2010) -  Drug safety and pharmacovigilance teams play a critical role before, during and after a product launch, but are not finding themselves...

Call for Survey Participants: Drug Safety and Pharmacovigilance Teams Subject of Study by Cutting Edge Information RESEARCH TRIANGLE PARK, NC--(Marketwire - January 25, 2010) - Drug safety and pharmacovigilance teams are facing increasing pressure to identify potential issues that could arise from the use of...